4.5 Article

Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis

Mehmet Zihni Bilik et al.

MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate

Catherine M. Shanahan et al.

CIRCULATION RESEARCH (2011)

Review Immunology

Immune and Inflammatory Mechanisms of Atherosclerosis

Elena Galkina et al.

ANNUAL REVIEW OF IMMUNOLOGY (2009)

Article Cardiac & Cardiovascular Systems

High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis

Omer Alyan et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)

Article Medicine, General & Internal

Overexpression of transforming growth factor-β1 in the valvular fibrosis of chronic rheumatic heart disease

Lucia Kim et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2008)

Editorial Material Medicine, General & Internal

Calcific aortic stenosis - Time to look more closely at the valve

Catherine M. Otto

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis

Heidi A. Eriksen et al.

ATHEROSCLEROSIS (2006)

Review Hematology

Pathogenesis of calcific aortic valve disease - A disease process comes of age (and a good deal more)

Kevin D. O'Brien

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Levels of circulating adhesion molecules in rheumatic mitral stenosis

E Yetkin et al.

AMERICAN JOURNAL OF CARDIOLOGY (2001)

Article Cardiac & Cardiovascular Systems

Matrix metalloproteinase expression in nonrheumatic aortic stenosis

ME Edep et al.

CARDIOVASCULAR PATHOLOGY (2000)